Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00337220 · ClinicalTrials.gov registry record
Urine Testing to Detect Kidney Transplant Rejection
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 492
- Enrollment target
NCT00337220 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 492 participants.
The verdict
NCT00337220 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 492 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if analysis of urine samples for specific markers can predict transplant rejection in people who have received kidney transplants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 492 participants |
| Start Date | 2006-06 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00337220
The ClinicalTrials.gov registry entry for NCT00337220 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 492 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00337220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00337220 about?
NCT00337220 is a clinical study titled "Urine Testing to Detect Kidney Transplant Rejection". The purpose of this study is to determine if analysis of urine samples for specific markers can predict transplant rejection in people who have received kidney transplants.
What is the current status of trial NCT00337220?
This trial is currently completed. The enrollment target is 492 participants. The study started on 2006-06. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT00337220?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.